Update on the safety of second generation antipsychotics in youths: A call for collaboration among paediatricians and child psychiatrists

Simone Pisano, G. Catone, Stefania Veltri, Valentina Lanzara, Marco Pozzi, Emilio Giuseppe Ignazio Clementi, Raffaella Iuliano, Maria Pia Riccio, Sonia Radice, Massimo Molteni, Annalisa Capuano, Antonella Gritti, Giangennaro Coppola, Anna Rita Milone, Carmela Bravaccio, Gabriele Masi

Research output: Contribution to journalArticle

Abstract

During the past decade, a substantial increase in the use of second generation antipsychotics (SGAs) has occurred for a number of juvenile psychiatric disorders, often as off-label prescriptions. Although they were thought to be safer than older, first generation antipsychotics, mainly due to a lower risk of neurological adverse reactions, recent studies have raised significant concerns regarding their safety regarding metabolic, endocrinological and cardiovascular side effects. Aim of this paper is to update with a narrative review, the latest findings on safety of SGAs in youths. Results suggest that different SGAs may present different safety profiles. Metabolic adverse events are the most frequent and troublesome, with increasing evidences of heightened risk for type II diabetes mellitus. Results are discussed with specific emphasis on possible strategies of an active monitoring, which could enable both paediatricians and child psychiatrists to a possible prevention, early detection, and a timely management of such effects.

Original languageEnglish
Article number51
JournalItalian Journal of Pediatrics
Volume42
Issue number1
DOIs
Publication statusPublished - May 21 2016

Keywords

  • Adolescents
  • Adverse events
  • Antipsychotics
  • Children

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Update on the safety of second generation antipsychotics in youths: A call for collaboration among paediatricians and child psychiatrists'. Together they form a unique fingerprint.

  • Cite this

    Pisano, S., Catone, G., Veltri, S., Lanzara, V., Pozzi, M., Clementi, E. G. I., Iuliano, R., Riccio, M. P., Radice, S., Molteni, M., Capuano, A., Gritti, A., Coppola, G., Milone, A. R., Bravaccio, C., & Masi, G. (2016). Update on the safety of second generation antipsychotics in youths: A call for collaboration among paediatricians and child psychiatrists. Italian Journal of Pediatrics, 42(1), [51]. https://doi.org/10.1186/s13052-016-0259-2